Osteogenesis imperfecta (01) is a genetically heterogeneous group of disorders caused by defects of collagen synthesis. Sillence et all proposed a classification of the disease into four types: types I and IV being autosomal dominant, and types II and III thought to be autosomal recessive. A recent refinement has been to divide types I and IV into subtypes A and B depending on the absence or presence, respectively, of dentinogenesis imperfecta.2 3 The characteristics of each type have been fully documented' 3 4 and most cases can be classified without difficulty on the basis of clinical features and family history. However, some sporadic cases may be hard to classify, since the distinction between a recessive case and a new dominant mutation is based solely on phenotype. In our view, there is little likelihood of error with type I mutants, but it may be difficult to distinguish type IV mutants from cases with type III.
An effect of paternal age on the liability to new mutation has been shown in other autosomal dominant disorders.5 6 In the case of 01, Vogel7 analysed 33 presumed mutants from Seedorff's series8 and found a positive and just statistically significant birth order effect. However, he pointed out that the analysis may have been misleading because of the possibility that parents may cease reproducing after Rcecived for publication 6 February 1985. Revised versioni accepted tfor ptiblicattioni 1( April 1985. the birth of an affected child. The 10 mutant type I cases reported by Sillence et all had a mean paternal age 2-1 years greater than that of population controls, but this difference was not statistically significant. Taken together, the two studies suggest that a small paternal age effect is present in OI mutants, but the low numbers involved and the methodological difficulties make such a conclusion unreliable. We present here an analysis of the paternal age effect in a much larger group of known or presumed mutant cases of dominant 01.
Patients and methods
Cases were ascertained as part of a large survey described previously.3 4 Table 3 shows the mean excess of maternal age in the same groups of cases. Among the mutants the mean maternal age was increased, though not significantly, by about 0(5 years, but was decreased relative to the controls after adjusting for paternal age. Similar figures for unadjusted maternal age Risk of dominant mutation in olderfathers were found in the group of cases born between 1935 and 1956 (table 4) . Of the individual subtypes, only type IA (n=38) was sufficiently represented in our sample to justify a separate analysis. The results were similar to those described above. Thus, the mean paternal age of type IA mutants was significantly increased by 2-9 years (p=0-01), and the increase remained significant when adjusted for maternal age (p=0-02). Mean maternal age was increased, though not significantly, by about 1-2 years, but was decreased relative to the controls after adjusting for paternal age.
Among the cases with dominant types of OI and an affected parent, mean paternal and maternal ages were reduced, significantly for maternal age (p-0O05). It is difficult to draw conclusions from this, since the reproductive histories of affected parents may be influenced by the knowledge of their condition.
The mean paternal age of the type III cases was increased, though not significantly, by about 09 years. Advanced paternal age has been implicated as a risk factor for mutation in several autosomal dominant disorders including achondroplasia, Apert's syndrome, and Marfan's syndrome. 6 There is also evidence for an association with advanced maternal grandpaternal age in a sex linked recessive disorder, haemophilia A. 13 In these conditions, the mean paternal age at birth of mutants is raised by five to eight years relative to population controls, an effect comparable in magnitude to that of maternal age in Down's syndrome. '4 In other presumed dominant conditions, however, the paternal age effect appears to be much smaller or even absent (for example, in bilateral retinoblastoma, neurofibromatosis, tuberous sclerosis, and aniridia5). Friedman14 has suggested that this difference is attributable, at least in some disorders, to the inclusion of misdiagnosed familial or recessive cases among the presumed mutants, and that it is therefore reasonable to assume that the true underlying paternal age effect for all autosomal dominant mutations is comparable to that for achondroplasia. He concludes, on the basis of this and other assumptions, that "the risk that a man who is over 40 years old will have a child with an autosomal dominant disease due to new mutation is no less than 0-3 to 0-5 per cent".
We believe that our results conflict with this argument. We have established that the paternal age effect in 01, although definitely present and attributable to paternal rather than maternal age, is considerably less than in achondroplasia (figure). Based on our data, a 95% confidence interval would exclude an increase in mean paternal age greater than about three years. Thus, to make our results consistent with Friedman's assumption, we should 
